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ABSTRACT: In this account, we describe the design, synthesis and applications of tethered
versions of the Ru(II)/N-tosyl-1,2-diphenylethylene-1,2-diamine (TsDPEN) class of catalyst that
are commonly used for asymmetric transfer hydrogenation and asymmetric hydrogenation of
ketones and imines. The review covers key aspects of the reaction mechanisms and examples of
applications, including industrial applications to pharmaceutically important target molecules. In
addition, closely related catalysts based on Rh(III) and Ir(III) are also described.
Keywords: asymmetric catalysis, hydrogenation, reaction mechanisms, supported catalysts, teth-
ered catalyst, transition metals
1. Introduction to Asymmetric Transfer
Hydrogenation
The asymmetric reduction of ketones and imines is a pivotal
method for the synthesis of chiral alcohols and amines, respec-
tively. Typically, such transformations are carried out using either
hydrogen gas, in the case of asymmetric hydrogenation (AH),[1]
or an alternative hydrogen source, such as secondary alcohols or
formates, in the case of asymmetric transfer hydrogenation
(ATH).[2,3] The majority of the earliest examples of catalysts for
AH reactions were based on precious-metal catalysts (usually Ru,
Rh or Ir) containing enantiomerically pure phosphine ligands,
with many excellent examples being reported through the 1970s
and ‘80s. In contrast, the development of ATH catalysis evolved
much more slowly at this time, with enantiomeric excesses (ee
values) remaining low and the scope limited. However, in 1995,
Noyori et al. published the first of a series of papers describing
complexes of Ru(II) that were to prove transformative to the field
of ATH of ketones and imines.[3b,4–7]
The innovative catalyst design by Noyori et al. required
the incorporation of a bidentate ligand containing at least one
NH function, as present in general structures 1 or 2 (Figure 1).
The presence of the NH function critically modified the mech-
anism of the hydrogen-transfer reaction.[1] Recent reviews[2]
give many examples that demonstrate that non-phosphine-
based catalysts with no bidentate ligand containing at least one
NH bond are active transfer hydrogenation catalysts.
The catalysts of general structures 1 or 2 are formed by in
situ combination of either an aminoalcohol or monotosylated
diamine, respectively, with the dimeric Ru(II) complex
[RuCl2(h
6-arene)]2 and base. In many cases, but not always,
the complexes could be isolated and many are commercially
available. The h6-arene ring is typically benzene, p-cymene,
1,3,5-trimethylbenzene or hexamethylbenzene. However, it is
catalyst 2, derived from N-tosyl-1,2-diphenylethylene-1,2-
diamine (TsDPEN) and where the arene is p-cymene,[8] that is
the most widely applied example.[9] These complexes are com-
monly referred to as Noyori catalysts in the context of ATH.
The complex in which the arene is 1,3,5-trimethylbenzene
instead of p-cymene repeatedly gives slightly higher enantiose-
lectivity in ATH and is also commercially available.
The mechanism of ketone reduction is closely related to
that of some hydrogenation complexes.[1] Upon activation
(usually in situ in a reaction), unsaturated complex 3 is formed
by elimination of HCl.[7] This complex then abstracts two
hydrogen atoms from the donor, typically isopropanol, formic
acid/triethylamine (FA/TEA) mixture or sodium formate, to
form hydride 4 (Figure 1). The isolation and characterisation
of the 16-electron complex 3 and the hydride derivative 4,[7]
coupled to mechanistic studies[10–12] and several computation-
al investigations,[8,13] have now provided an insight into the
process of asymmetric induction. Importantly, complex 4 is
formed predominantly as one diastereoisomer, rendering the
Ru atom chiral and of one configuration. An outer-sphere
mechanism subsequently operates, in which both hydrogen
atoms are transferred to the ketone substrate by a concerted
mechanism (Figure 2). In addition, a stabilising edge/face (or
CH/p) electrostatic interaction favours the positioning of the
substrate aryl group adjacent to the h6-arene ring of the cata-
lyst in the transition state. This ensures that a predictable
major enantiomer of product is formed.[8,13] However, it
should be noted that a minor hydride is often observed during
in situ studies of the reduction reactions.[14] This may be due
to the formation of a less reactive minor diastereoisomer of the
hydride.
Ketones containing a combination of aromatic and ali-
phatic groups (which herein are termed acetophenone
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derivatives) are usually reduced in high enantioselectivity, and
many examples have been reported. Ketones flanked by two
different aliphatic groups, on the other hand, are generally
reduced in low ee due to a lack of purely steric-based discrimi-
nation, although some examples are described later. As a result
of the unusually high dependence on electronic control, an
interesting beneficial effect is the reduction, in moderate, but
surprisingly good, ee, of a ketone containing two different aro-
matic rings; the more electron-rich one interacts with the h6-
arene of the catalyst (Figure 3).[3b,5]
Although electrostatic interactions appear to be critical,
results from molecular modelling have revealed that dispersion
forces, solvent effects and steric effects also contribute to the
enantioselectivity.[13e] The concerted nature of hydrogen trans-
fer has also been the subject of closer investigation in recent
years; more detailed recent modelling studies have also indicat-
ed that the hydrogen-transfer step is not fully concerted.[13g]
Furthermore, the same mechanism cannot be applied to C5N
reductions, which appear to operate through an open transi-
tion state.[11,12,15]
The Noyori catalysts (2) for ATH have now been exten-
sively applied to synthetic applications,[9] and research efforts
are ongoing, even 20 years after their initial introduction. In
addition, the isoelectronic Rh(III) and Ir(III) derivatives, con-
taining a cyclopentadiene ligand in place of the benzene ring
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Fig. 1. Non-tethered Ru(II) complexes for ATH reactions.
Fig. 2. Mechanism of hydride transfer from Ru/TsDPEN complex to a
ketone.
Fig. 3. Stereoelectronic effects control the sense of asymmetric reduction.
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on the metal, have been introduced and widely studied
(Figure 4).[16]
2. The Rationale behind the Tethered Catalyst
Design
In the early 2000s, Wills et al. sought to modify the
[Ru(II)(TsDPEN)(h6-arene)] design by introducing a struc-
tural modification in the form of a tether between the h6-arene
and the diamine(or aminoalcohol) ligand. By preventing the
inevitable rotation of the h6-arene, it could be decorated with
functional groups that would modify its catalytic properties.
For example, the introduction of large groups selectively at
positions 3 and 5 might be able to switch the selectivity from
electronic to steric control by forcing the larger substrate group
away from the h6-arene (Figure 5). Another speculation was
the possibility of the inclusion of directing groups, which
could create hydrogen bonds to substrates, and hence, direct
their selective reduction.
In 2004–2005, Wills et al. introduced a series of new cata-
lysts, 5–8, each containing the required tethering moiety (Fig-
ure 6). The Rh(III)/Cp* complex 5 was derived from an
amino alcohol,[17] as was the Ru(II) complex 6,[18] whereas 7
and 8 were prepared from DPEN.[19–21] The aminoalcohol
derivatives 5 and 6 proved to be effective as catalysts, but were
not very stable, whereas the diamine-derived catalysts worked
more effectively. Linking through the SO2 group (in 7) was
initially tested, since it was felt, at the time, that it was essential
to have a primary amine for optimal activity,[5] and in this
respect compound 7 worked effectively, but was no more active
than the untethered complex. More success, and through a
shorter and more efficient synthesis, was however achieved by
linking the h6-arene to the diamine through the basic N group
to create catalyst 8.[20,21] On a small scale, early samples of this
complex, and related derivatives, can be purified by chroma-
tography on silica gel, and are robust in reductions, with no
exceptional requirements for oxygen exclusion. Tethered com-
plex 8 proved to be highly active in reduction reactions under
transfer hydrogenation conditions. For example, acetophenone
([S]52M, FA/TEA) reduction using 0.5 mol% of 8 at 40 8C
went to completion within 3 h (without significant erosion
of ee), whereas the same reaction with an untethered catalyst
required 24 h.[21] This allowed the catalyst loading of 8 to be
reduced to 0.01 mol%, giving a product in 98% conversion in
84 h and 96% ee; notably, a very low background reverse reac-
tion is observed, and hence, long reaction times do not result
in reduced ee values. In 2006, a mg sample of catalyst 8 was
supplied to Johnson Matthey. The catalysts, tested against
complex poly-functionalised targets, were quickly found to
outperform first-generation Noyori catalysts in terms of activi-
ty and resilience to deactivation (unpublished results).
Due to the modular nature of the synthetic approach, it is
possible to change the sulfonyl group and the length and type
of tether. Through these modifications, there is potential for
the rapid optimization of the catalysts towards specific target
molecules. Several of the modified tethered catalysts, described
both by ourselves and by others, are described in more detail in
the next section. The success of the tethered catalyst design led
to the subsequent development of a number of other catalysts,
including Ts-DENEBV
R
9 and the Mohar catalysts 10 and 11
(several structural variants; Figure 7).
Fig. 5. Tethered catalyst design and concept for switching to steric control of
reduction.
Fig. 6. Examples of early tethered catalysts.
Fig. 7. Later tethered catalysts.
Fig. 4. Rh(III) and Ir(III) Cp* complexes of TsDPEN used in ATH.
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3. Synthetic Approaches to Tethered Catalysts
Synthetic approaches to the tethered catalysts differ in the way
the precursor containing the cyclohexadienyl linked to
TsDPEN (12) is produced. Compound 12 is reacted as a
hydrochloride salt with RuCl3 to form the [RuCl2(arene)]2
dimer 13. The treatment of dimer 13 with a mild base removes
HCl from the TsDPEN moiety, allowing coordination of the
diamine followed by removal of a further mole of HCl to form
7 (Figure 8).[20,21] Precursor 12 was initially synthesized using
reductive amination between cyclohexadienyl–alkylcarbalde-
hyde and TsDPEN. Unfortunately, the formation of an aminal
impurity required chromatographic purification of 12. As the
synthesis of 12 was developed at Johnson Matthey, monoalky-
lation of the TsDPEN moiety by an sulfonate activated
cyclohexadienyl-alkanol was demonstrated to give better yields
of 12 with a purity that could be used in downstream chemis-
try.[22] As a further modification to the initial synthesis using
Birch reduction to yield the cyclohexadienylalkanols, a Diels–
Alder reaction can be used to create the precursor, notably for
para-substituted h6-arenes.[23,24]
The route through alkylation of monosulfonated dia-
mines to yield ligands of type 12 has been applied to several
target structures, demonstrating the scope of this improve-
ment.[25] Firstly, Johnson Matthey have used this approach for
the commercial synthesis of kg quantities of 8 and derivatives.
We have investigated the synthesis of a range of complexes 14–
17 with smaller (methanesulfonyl (Ms)), larger (2,4,6-trime-
thylphenylsulfonyl (Mts) and 2,4,6-triisopropylphenylsulfonyl
(Tris)) and electron-poor (pentafluorophenyl)sulfonyl groups
(Figure 9).[25] The synthetic approach based on alkylation of
the sulfonylated diamine ligands with a cyclohexadienyl moie-
ty has found broad application (see subsequent sections on
ether- and amine-tethered catalysts).
We have also described alkylene-tethered catalysts con-
taining tethers of different lengths and with methyl groups on
the h6-arene ring: 18–25 (Figure 10).[26–28] Achiral versions
of the tethered catalysts (e.g., 25) have also been prepared and
used in synthetic applications.[22] Other complexes, which
have been prepared through the 1,4-cyclohexadiene route,
include the 1,2-cyclohexyldiamine-based complex 24 and
benzyl-bridged 22;[27] both are competent catalysts.
Although the stable, isolated monomeric complexes are
normally used in catalytic applications, the chloride-bridged
ruthenium dimer can also be used directly in reactions in FA/
TEA because it is converted into the monomer in situ.[20]
3.1. Catalysts with an Ether Tether
The idea of replacing the alkylene tethering chain by one con-
taining heteroatoms was independently put into practice by
two groups, each including members from academia and
industry (Figure 11). A group led by Ikariya and championed
by Takasago, prepared what has now been commercialized by
Takasago as Ts-DENEBV
R
.[24] The approach by Ikariya et al.
employed a Williamson ether synthesis between metal precur-
sor 26 and N0-hydroxyethyl-functionalized TsDPEN 27 to
make the final monomeric complexes. The alternative route by
Wills et al., and championed by Dr. Reddys, UK, first
Fig. 8. Synthetic approaches to tethered Ru(II) catalysts.
Fig. 9. New tethered Ru(II) catalysts for ATH.
Fig. 10. Tethered catalysts formed using the approach outlined in Figure 8.
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assembled the TsDPEN ligand bearing the tethered cyclohexa-
dienyl moiety 28, followed by coordination to Ru and base-
induced formation of the monomeric complex.[29] Although
Wills et al. still used the reductive amination reaction for the
ligand synthesis, synthesis of this ligand by direct alkylation
has also been demonstrated.[24]
In common with the original tethered catalyst 8, its close
derivatives are stable crystalline solids.
3.2. Tethered Catalysts with Sulfamoylamino (NSO2N)
Groups
In very recent studies, Mohar et al. reported tethered Ru(II)
catalysts 10 and 11, containing a sulfamoylamino (NSO2N)
unit in place of the more widely used sulfonamide unit (Figure
12). In the case of 10, the tether was attached through the
NSO2N group,
[30,31] and in the later version 11 R2NSO2
replaced the tosyl group in 8.[32] For the synthesis of 10, firstly,
the imidazole-containing starting material 29 was prepared.
This was activated by N-methylation and then subsequent sub-
stitution with DPEN led to formation of ligand precursor 30.
Protonation and complexation with RuCl3 gave dimer 31,
which could be readily isolated and used directly in reduction
reactions in FA/TEA mixture (presumably via the formation
of 10). Attempts to isolate 10 were unsuccessful, however, and
the monomeric active species was formed in situ during appli-
cations. Through this approach, several derivatives of 10 were
prepared with varying tether lengths and arene substitution.
However, attempts to form 10 through an arene-exchange
strategy were also unsuccessful.[31]
For complexes 11, a modification of the established proto-
col through alkylation of a triflate derivative was employed,
using R2NSO2DPEN in the displacement step, followed by
complexation with RuCl3 to give dimer 32. The dimer was
again used directly in catalytic experiments, since monomer 11
could not be isolated. All ligands containing DPEN attached
to a cyclohexadiene group, prepared by us and Mohar et al.,
readily formed the [RuCl2(arene)]2 dimer complexes;
[25,32]
however, the latter had to use the dimer as a pre-catalyst for
catalytic experiments.
3.3. g6-Arene Ligand Exchange Route
In the case of 1,4-cyclohexadiene precursors that are electron-
rich or highly functionalised, attempts at complexation result
in prior aromatisation of the diene before it has formed a com-
plex. This was reflected in a paper by Bennett et al., in which it
was reported that the Birch reduction of hexamethylbenzene
could not be readily achieved.[33]
A potential solution to this problem, and attractive in its
elegance, is the direct formation of a tethered complex through
intramolecular h6-arene exchange. Unfortunately, all of our
attempts to achieve this reaction in an intramolecular manner
from a preformed complex failed to give more than 15% con-
version of highly impure material. Whilst there are many
examples of cyclisations through arene substitution of Ru–P-
type ligands,[34] there are only two precedents for cyclisations
of Ru–N-type complexes, and both of very simple struc-
tures.[35,36] However, a solution to this problem was recently
found by rapid heating of the reaction of a precursor ligand,
such as 33, in the absence of base, or in the presence of a mild
base (Figure 13).[37] Through this route, complexes 34 and 35
were prepared and isolated. Both new catalysts, and a series of
further derivatives, all proved to be competent catalysts in
ATH reactions.
The electron-rich derivatives 34 and 35 are stable crystal-
line solids that can be purified by flash chromatography and
even analysed by open TLC analysis.
4. Application to Reductions of Acetophenone
Derivatives
One of the striking (and unexpected) features of the tethered
catalyst 8, and of many of its derivatives, is its high activity rel-
ative to the untethered (Figure 14).[20,21] Increased activities
Fig. 12. Synthesis of tethered complexes 10 and 11.
Fig. 11. Synthetic approaches to catalysts with an oxygen-containing tether.
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have been observed across a range of substrates and in one strik-
ing result the very hindered substrate tBuCOPh was reduced in
95% conversion after 32 h and in 77% ee (0.5 mol% catalyst at
40 8C, FA/TEA).[20] In contrast, this substrate is reported to be
resistant to reduction by the untethered catalysts (<1% reduc-
tion reported under the same conditions).[3b]
In further studies, it was found that additional quantities
of ketone substrate and FA could be added to the reaction
medium and each portion was sequentially reduced in good ee,
indicating that the catalyst remained active and stable for
extended periods.[20] The untethered catalyst is prone to degra-
dation (with the speculation of nanoparticle formation),[38]
and also to dissociation of the ligand under low-pH condi-
tions;[39] however, the tethered catalyst appears to benefit from
significantly improved stability, which may account for many
of the improved results observed.[40]
A study of the substrate scope and reactivity of a small
range of tethered catalyst derivatives indicated that those with
three or four carbon atoms in the tether (notably, 8 and 19)
were the most effective, whereas the shorter or longer tether
catalysts were not as active.[26,28] Tethered catalysts, including
the original 3-C-tethered 8, and the recently disclosed deriva-
tives, have been applied to the ATH of a range of acetophenone
derivatives. Such substrates are generally reduced in high enan-
tioselectivity and some representative data, for the FA/TEA
system at T528–60 8C, are listed in Table 1. The absolute
configurations of the products match those predicted using the
general model for acetophenone reduction and depend on
which catalyst enantiomer was used. The published data offer
the opportunity to compare the performance of various teth-
ered catalysts with the first-generation Noyori catalysts (some
are reported in Table 1). Although the catalysts show broad
acceptance of a variety of acetophenone derivatives, as is often
the case in catalysis, no single catalyst excels on all transforma-
tions and an appropriate matching of the substrate with the
catalysts must be sought. In addition, it should be kept in
mind that, in case of a requirement for a preparative synthesis,
most reactions can be further optimized by working on the
choice of solvents, temperature and hydrogen donor. The
ATH of more specialized substrates is described in later sec-
tions and the list in Table 1 is designed to be illustrative rather
than exhaustive; further examples are given in the references.
Although not included in Table 1, the 4-C-tethered catalyst 19
is marginally more active in ATH than 3-C 8, but gives prod-
ucts in similar ee.[26] The electron-rich complex containing a
3,5-dimethoxy substitution pattern (i.e., 35) is generally less
enantioselective for aromatic ketones than the 4-methoxy cata-
lyst 34.
In an effort to further explore the structural and electronic
space of these catalysts, variation of the sulfonamide group was
investigated.[25] All of these catalysts, with tethered lengths of
three and four carbon atoms, worked efficiently, although the
advantages of varying sulfonyl group substitution and length
of the tether becomes particularly evident on certain substrates
(see the next section). As an example, the full reduction of a-
hydroxyacetophenone was achieved in 5 h using just 0.01
mol% of the Tris catalyst 17 (n51) in>95% ee (Figure 15).
On some substrates (e.g., acetophenone, tetralone), varia-
tion of the sulfonyl group and the length of the tether leads to
modest changes in reactivity and enantioselectivity.[25] On the
contrary, there are more difficult substrates, such as 3,5-bis(tri-
fluoromethyl)acetophenone, for which a remarkable swing in
enantioselectivity is observed from the Ts- and Ms-substituted
catalysts (Figure 16 features additional examples not in Table
1), for example, (R,R)23-C Ts 8 (56% ee (R)) to catalysts with
larger MTs and Tris substituents, such as (R,R)24-C-Tris 17
(n52) (81% ee (S)).
Fig. 14. Comparison of reaction times for increasingly hindered
acetophenone derivatives.
Fig. 13. Arene-exchange strategy to tethered complexes.
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Table 1. Comparison of reductions of a range of acetophenone derivatives using tethered catalysts with HCO2H/Et3N.
[[a]]
Ketone
Cat. 2
(p-cymene)[3b,5]
Tethered cat.
8[20,21,26]
Tethered
p-OMe cat.
34[37]
DENEBV
R
9[b][24,29]
Sulfamoyl cat.
10[c,d][30,31]
Sulfamoyl
cat. 11[c][32]
3-C Ms cat.
14 (n51)[25]
3-C Tris cat.
17 (n51)[25]
4-C Ts
cat. 19[25]
>99% yield
98% ee
(0.5% cat.
288C, 20h)
100% conv.
96% ee
(0.5% cat.
408C
3h)
100conv.
96% ee
(0.1% cat.
608C
2h)
>99%yield
97% ee
(0.1% cat.
608C
3h)
>99%conv.
94% ee
(0.5% cat.
608C
2h)
100% conv.
96.2% ee
(0.1% cat.
608C
8.5h)
100% conv.
96% ee
(0.2% cat.
408C
5h)
85%conv.
96% ee
(0.2% cat.
408C
24h)
100% conv.
96% ee
(0.2% cat.
408C
5h)
>99%yield
97% ee
(0,5% cat.
288C
60h)
100% conv.
94% ee
(0.5% cat.
408C
1.6h)
– – 95%conv.
93% ee
(1% cat.
408C
20h)
– 100% conv.
95% ee
(0.2% cat.
408C
24h)
91%conv.
92% ee
(0.2% cat.
608C
24h)
96%conv.
95% ee
(0.2% cat.
408C
7h)
>99%yield
98% ee
(0.5% cat.
288C
60h)
100% conv.
94% ee
(0.02% cat.
408C
20h)
– – 100% conv.
98% ee
(0.5% cat.
608C
2h)
–
– 100% conv.
68% ee
(0.5% cat.
408C
3h)
100%conv.
96% ee
(0.1% cat.
608C
1.5h)
>99% yield
93% ee
(0.1% cat.
608C
24h)
100% conv.
93% ee
(1% cat.
408C
15h)
– 91%conv.
60% ee
(0.2% cat.
408C
24h)
94%conv.
22% ee
(0.2%
408C
24h)
96%conv.
95% ee
(0.2%
408C
5h)
>99%yield
98% ee
(0.5% cat.
288C
36h)
100% conv.
98% ee
(0.5% cat.
408C
3h)
100%conv.
98% ee
(0.1% cat.
608C
2h)
>99%yield
98% ee
(0.1% cat.
608C
5h)
– 100% conv.
98.3% ee
(0.1% cat.
408C
15h)
– 100% conv.
97% ee
(0.5% cat.
408C
3h)
– – – 100%conv.
96.8% ee
0.1% cat.
408C
15h
– 100% conv.
96% ee
(0.5% cat.
408C
3h)
>99% conv.
97% ee
(0.1% cat.
608C
1h)
>99%yield
97% ee
(0.1% cat.
608C
5h)
– – 72%conv.
>95% ee
(0.2% cat.
408C
3h)
100% conv.
93% ee
(0.2% cat.
408C
1h)
96%conv.
96% ee
(0.2% cat.
408C
1h)
– – 100% conv.
98% ee
(0.1% cat.
608C
2h)
98%yield
96% ee
(0.1% cat.
608C
5h)
– – 100% conv.
>95% ee
(0.2% cat.
408C
6h)
99%conv.
96% ee
(0.2% cat.
408C
5h)
100% conv.
>95% ee
(0.2% cat.
408C
5h)
– – 100% conv.
98% ee
(0.1% cat.
608C
1h)
>99%yield
95% ee
(0.1% cat.
608C
5h)
100% conv.
96% ee
(0.5% cat.
608C
1h)
–
93%yield
83% ee
(0.5% cat.
288C
– 100% conv.
99% ee
(0.1% cat.
608C
94%yield
84% ee
(0.1%
608C
100%yield
99.9% ee
(0.5% cat.
408C,
–
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Wills et al. found that Ts-DENEBV
R
9 was unable to
reduce 2-acetylpyridine, whereas 3-C 8 gave a product with
94% ee (100% conv.) at 0.5 mol% loading (40 8C, 30 min)
and 91% ee (100% conv.) at just 0.02 mol% loading (40 8C,
20 h).[29] Further tests revealed that 2-acetylpyridine inhibited
Ts-DENEBV
R
9, possibly due to a hydrogen-bond interaction
of the protonated substrate with the catalyst.
The reduction of benzil (PhCOCOPh) to chiral (S,S)-
hydrobenzoin is well established as an easy transformation.[41]
This reduction was chosen to compare Ts-DENEBV
R
with C4-
tethered 19. The reduction at 60 8C using just 0.001 mol%
catalyst gave (S,S)-hydrobenzoin with >99% ee and a DL/meso
ratio of 97.2:2.8. A difference in the rate of the reaction was
observed without a report of the purity of the employed
catalysts.
The N,N-dialkylsulfamoylamino-DPEN-derived class of
catalysts introduced by Mohar et al., namely, 10 and 11,[30,32]
also perform very efficiently in ATH and appear to be particular-
ly suited to the reduction of 1-naphthyl ketones.[30] Although
not described in detail herein, a very comprehensive survey of
the reductions of this class of substrate was carried out, with
excellent results. One interesting result, however, was that 10-
acetonaphthone containing a 20-OMe group was inert to reduc-
tion. Mohar et al. also commented on the observation of higher
conversions using the tethered catalysts compared with the cor-
responding untethered sulfamoylamino-based ones, presumed
to be a consequence of their significantly higher stability. These
catalysts also worked well in the reduction of diketones to form
diols (not illustrated), and the catalysts of class 11 gave some of
the highest ee values recorded for reductions of benzo-fused
ketone substrates (representative examples in Table 1).[32]
Notable within the examples in Table 1 are acetophenones
containing a potentially sensitive a-chloro substituent, which
provide access to valuable synthetic intermediates. In addition,
several ketones containing a-substituents and heterocyclic
groups have been demonstrated to be compatible with catalyst
8 (Figure 17).[26]
Table 1. (Continued )
Ketone
Cat. 2
(p-cymene)[3b,5]
Tethered cat.
8[20,21,26]
Tethered
p-OMe cat.
34[37]
DENEBV
R
9[b][24,29]
Sulfamoyl cat.
10[c,d][30,31]
Sulfamoyl
cat. 11[c][32]
3-C Ms cat.
14 (n51)[25]
3-C Tris cat.
17 (n51)[25]
4-C Ts
cat. 19[25]
36h) 3h) 24h) [e] 5h) [f ]
>99% yield
96% ee
(0.5% cat.
288C
22h)
– 100% conv.
94% ee
(0.1% cat.
608C
2h)
– 100% conv.
96% ee
(0.5% cat.
608C
2h)
–
– 100% conv.
99% ee
(0.1% cat.
608C
3h)
>99%yield
>99% ee
(0.1% cat.
608C
5h)
– 100%conv.
99.9% ee
(0.1% cat.
608C
3h)
>99% yield
99% ee
(0.5% cat.
288C
48h)
– 99%conv.
99% ee
(0.1% cat.
608C
5h)
85%yield
98% ee
(0.1% cat.
608C
24h) [g]
100% conv.
99.9% ee
(0.5% cat.
408C
20h)
100%conv.
99.4% ee
(0.1% cat.
608C
2h)
95%conv.
98% ee
(0.2% cat.
408C
24h)
82%conv.
99% ee
(0.2% cat.
408C
24h)
100% conv.
95% ee
(0.2% cat.
408C
5h)
– – 100% conv.
99% ee
(0.1% cat.
608C
3h)
– 100%conv.
97% ee
(0.5% cat.
408C
7h)
100conv.
94.5% ee
(0.1% cat.
608C
2h)
[a] Typical conditions. unless otherwise listed: FA/TEA, 408C, [S]5ca. 2M. [b] DENEB results from Ikariya et al. For results on similar substrates at 308C and 0.5
mol% catalyst loading, see the paper by Wills et al. [c] Supplied to the reaction in the form of the dimer and presumed to be converted into monomer in situ. [d]
Results are usually for the catalyst in which a 2C chain is present on the tether and a 4-methyl is on the g6-arene ring, but in some cases are for the best-performing cat-
alyst. [e] 97% ee with MsDENEBV
R
. [f ] 0.1% catalyst requires 22h. [g] On cycloheptyl analogue, using MsDENEBV
R
Fig. 15. ATH of a-hydroxyacetophenone using 17 (n51).
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The recently disclosed electron-rich complex 34 proved to
be very effective in the reduction of ketones; it is noteworthy
that due to their high stability, the reactions could be run at
60 8C using just 0.1 mol% of catalyst, but without any signifi-
cant drop in ee. Substrates containing ortho-methoxy groups
were exceptionally compatible, giving products of up to 96%
ee, compared with about 68% ee observed using 7. Figure 18
illustrates the reductions of a series of ortho-substituted ketones
where the methoxy-substituted catalyst gives an improved
outcome.[42]
4.1. ATH inWater
Many examples have been published on the use of Ru(II)/
TsDPEN catalysts under aqueous conditions (with sodium for-
mate).[43] Tethered catalysts, likewise, are efficient under these
conditions. Figure 19 summarises a series of reductions using
the electron-rich catalyst.[42]
Electron-rich ketones, for example, containing alkoxy and
amine substituents, are known to be challenging substrates for
reduction.[44] However, in recent work, we were able to estab-
lish that tethered catalysts could reduce these efficiently under
aqueous conditions (Figure 20).[42] The untethered catalyst is
less active.
4.2. Alternative Hydrogen Donors
Williams et al, while examining the potential for use of an
alternative hydride source in transfer hydrogenation, stressed
Fig. 16. Best catalyst for the reduction of specific ketones from the series with
varied sulfonyl groups and tether lengths.[25]
Fig. 17. ATH products from a-substituted acetophenones and heterocyclic
ketones reduced by catalyst 8 and 19 (408C, FA/TEA, 0.5 mol% catalyst).
Fig. 18. Comparison between catalysts 8 and 34 in the reduction of ortho-
methoxyacetophenone.
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the superior activity of tethered catalyst 8 in the reduction of
acetophenone derivatives in the presence of cis-1,4-butenediol
(Figure 21).[45] The diol provides an efficient source of hydro-
gen through isomerisation first to 4-hydroxybutanal, lactol for-
mation, and its subsequent irreversible oxidation to the
lactone. In particular, the higher activity of the tethered catalyst
permitted the reaction to be run at a lower temperature than
would otherwise be required.
5. Application to Other Substrates: Beyond
Acetophenone Derivatives
5.1. Reduction of Dissymmetric Alkyl Ketones
The striking lack of applications of Ru-TsDPEN/arene cata-
lysts to the reduction of dissymmetric alkyl ketones indicates
that they are poor catalysts for this class of substrate.[46] Teth-
ered catalyst 8 does, however, reduce acetylcyclohexane in a
valuable 69% ee.[26] We found that the addition of a 4-Me
group to the h6-arene had little effect on the selectivity or
activity, whereas, in contrast, 3,5-dimethyl-substituted catalyst
23 gave much better selectivity with an ee of 89% for this sub-
strate (Figure 22).[26] The fact that for this reduction the cata-
lyst derived from the (R,R)-DPEN ligand gives the S-
configuration product (vs. the R-configuration alcohol from
acetophenone) indicates that the reduction is likely to be
directed by steric effects rather than electronic ones, that is, the
larger methyl groups force the larger group in the substrate
into the more distal position (Figure 22). A similar trend is
seen using the 4-OMe complex 34 (gives product in 37% ee)
versus the 3,5-dimethoxy complex 35, which gives the product
in 73% ee.[37] Ts-DENEBV
R
9 gave essentially no asymmetric
induction in the reduction of this acetylcyclohexane.[29]
Fig. 19. Ketone reduction in water using catalyst 34.
Fig. 20. ATH of electron-rich acetophenones with tethered catalysts.
Fig. 21. ATH using catalyst 8 with cis21,4-butenediol as a hydrogen source.
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Due to the high reactivity of tethered catalysts, hindered
ketones can be reduced in surprisingly high enantioselectiv-
ities, including several examples with adjacent quaternary
centres, with the suggestion of a second directing effect operat-
ing.[47] This study arose from an unexpected observation that
the 1,1-dimethyl derivative of b-tetralone was reduced in
higher ee than the unsubstituted derivative; this was surprising
because previous results suggested that the introduction of
additional hindrance would reduce the selectivity.[20] The
reduction of an extended series of b-tetralones revealed an
increase in ee as the substituents became larger (Figure 23).
Our speculation for the control of this reaction was that
an additional controlling interaction was operating (Figure 24)
with further contributions from both electrostatic and disper-
sion forces contributing to the observed selectivity.
As evidence of this hypothesis, the new directing effect
could be used by itself to direct further reactions. Examples are
shown in Figure 25.
In all of the above examples, the presence of substituents
a to the carbonyl group to be reduced appears to play a funda-
mental role in assuring good enantioselectivity. Shipman et al.
used tethered catalyst 8 (as well as an untethered catalyst) in
the synthesis of a functionalised tetrahydroxanthone related to
kigamicin A (Figure 26),[48] but the product ee was modest,
although superior to that obtained with the first-generation
untethered catalyst.
5.2. Reduction of Alkynyl Ketones
In agreement with the observations made with non-tethered
catalysts,[6q–u] acetylenic ketones are excellent substrates, and
have been studied and employed extensively in many reported
applications. The tethered catalysts have proved valuable and
have been used in processes for the synthesis of propargylic
alcohols in excellent ee.[49,50] They have also proven to be
active without any need for pre-formation of the 16-electron
species, which had been required in previous applications of
first-generation catalysts.[6q–u] In our own work, we found that
b-, g- and d-keto esters were excellent substrates, with the
absolute stereochemical control appearing to follow the general
rule that the triple bond occupies the position of the aromatic
ring in reductions (Figure 27).
Fig. 22. ATH of acetylcyclohexane.
Fig. 23. ATH of hindered b-tetralone derivatives.
Fig. 24. Control of enantioselectivity in b-tetralone reduction.
Fig. 25. Products of ATH of ketones adjacent to quaternary centres using
catalyst 8.
P e r s o n a l A c c o u n t T H E C H E M I C A L R E C O R D
Chem. Rec. 2016, 16, 2623–2643 VC 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Wiley Online Library 2634
In one application, the alkyne directing effect could be
used twice in a sequence to deliver a diol product, following
alkyne reduction (Figure 28).[49a]
Dynamic kinetic resolution (DKR) with tethered catalysts
was also achieved (Figure 29a).[49a] Ratovelomanana-Vidal
et al. (with Roche) reported an analogous reduction of the
a-methoxy series of substrates.[51] In several cases, it was essen-
tial to use the tethered catalysts because the non-tethered ones
failed to give acceptable results (Figure 29b).
An interesting class of substrate for ATH are 2,2-dimeth-
yl-6-(2-oxoalkyl/oxoaryl)21,3-dioxin-4-ones because their
asymmetric reduction provides the basis for the synthesis of 5-
hydroxy-3-ketoesters.[49b] Asymmetric reduction leads to
products with ee values of up to 98% and the subsequently
deprotected ketone can be further reduced in a (known) dia-
stereoselective process to either the cis or anti products. This
sequence has been applied to the synthesis of (1)-yashabushi-
triol and one of its diastereoisomers; the final reduction selec-
tivity is controlled by the catalyst and directed by the alkyne
(Figure 30).
Dialkynyl ketones can also be reduced in high ee, although
there is a requirement for the use of a large amount of catalyst
Fig. 26. A key ATH step in the synthesis of kigamycin A.
Fig. 27. ATH of acetylenic b-, c- and d-keto esters and diketones.
Fig. 28. Application of ATH to the synthesis of yashabushidiol.
Fig. 29. ATH coupled to DKR.
Fig. 30. ATH of 2,2-dimethyl-6-(2-oxoalkyl/oxoaryl)21,3-dioxin-4-ones.
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to ensure rapid reduction before side reactions can take place
(Figure 31).[50]
5.3. Other Transformations
A clever azide reduction/imine hydrolysis linked to ketone
reduction by tethered catalyst 8 led to an asymmetric synthesis
of a lactone through reduction and lactonisation (Figure
32a).[52] A closely related sequence on vinylic azides led to the
asymmetric synthesis of a-hydroxy esters (Figure 32b).[53]
The reduction of trichloromethyl ketones was reported by
Fox et al.[54] In many cases, the untethered catalysts gave good
results; however, the tethered catalysts were very effective in
several cases (Figure 33).
6. ATH of Substrates of Industrial Interest
Both Ru tethered catalysts 8 and 9 (Ts-DENEBV
R
) have gener-
ated significant industrial interest. Following initial reports on
the tethered catalyst by the Wills group, Johnson Matthey
developed a large-scale approach to carbon tethered catalysts.
Early interest came from industrial research groups who had
obtained promising results with research samples of C3-
tethered catalyst 8 from the Wills group and Johnson Matthey.
AstraZeneca have used 8 to prepare anti-asthmatic bron-
chodilator drug structures; the reduction step was the
penultimate step in the synthesis and the reduction was not
only enantioselective, but also chemoselective (Figure 34a).[55]
Synthon BV described a synthesis of the established anti-
asthmatic drug montelukast.[56] In this application, the teth-
ered catalyst 8 was highlighted as giving excellent results in the
transfer hydrogenation reaction (Figure 34b). Archimica
GMBH reported the synthesis of the antiepileptic drug eslicar-
bazepine through reduction of a cyclic ketone (Figure 34c).[57]
The commercial availability of the Wills carbon tethered
catalyst from Johnson Matthey and Ts-DENEBV
R
from Taka-
sago, and the availability of both from catalogue companies
has been a significant step towards finding commercially viable
applications.
Fig. 31. ATH of dialkynyl ketones.
Fig. 32. Azide reduction coupled to ketone reduction.
Fig. 33. ATH of trichloromethyl ketones.
Fig. 34. Pharmaceutical applications of tethered catalyst 8.
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From the perspective of industrial applications, it is
important that the new classes of tethered catalysts (which are
structurally more complex than first-generation catalysts and
have a more involved synthesis) not only offer advantages, but
also allow transformations that were previously impossible or
gave unacceptable levels of conversion or selectivity.
The robustness of the tethered catalysts in the presence of
poly-functionalized molecules is one of the features that make
them particularly attractive for the reduction of functional
groups in complex substrates of interest to the life sciences
industry. The increased reactivity and stability provided by the
tethered catalyst design can render it the reagent of choice,
even when an asymmetric induction is not required. For exam-
ple, the reduction of 36 to 38 proved to be very challenging
and not compatible with most well-established catalytic and
stoichiometric reagents. However, a successful route was devel-
oped by Eli Lilly in collaboration with Johnson Matthey using
an achiral tethered catalyst derivative[22] in the first step to
form intermediate alcohol 37. This was followed by a carefully
optimized hydrogenolysis in the second step (Figure 35).[58]
As little as 0.01 mol% of the achiral catalyst was required in
the first reduction; ammonium formate was conveniently used
as the reducing agent.
Boehringer Ingelheim GmbH used tethered catalyst 7 to
prepare an intermediate toward the synthesis of chemokine
inhibitors (anti-inflammatory agent). Notably, 40 g of product
D was formed using just 20 mg of the tethered catalyst
(Figure 36), in sufficient purity to be used directly in the next
step (w/w ratio of 2000/1).[59]
In 2015, Komiyama et al. reported the application of Ms-
DENEBV
R
39 (the N-Ms derivative of Ts-DENEBV
R
) to the
synthesis of an adrenergic receptor agonist through ATH of an
a-amino ketone precursor (Figure 37).[60] The Ms-DENEBV
R
catalyst 39 outperformed Ts-DENEBV
R
9, while the non-
tethered [RuCl(R,R)-TsDPEN(p-cymene)] catalyst was even
more enantioselective then the Ts-DENEBV
R
catalyst.
The DKR of a cyclic ketone has been reported by Lek
Pharmaceuticals (Sandoz).[61] In this process, 1 mol% of teth-
ered catalyst 8 achieved full reduction to the syn isomer in
>100:1 selectivity and 99% ee (Figure 38). Although a very
similar transformation had been previously reported using the
non-tethered catalyst,[62] the presence of an electron-rich sub-
stituent on the fused aromatic ring made the reduction more
difficult and less than 20% conversion was achieved with the
non-tethered catalyst. The tethered catalysts could also be used
under hydrogenation conditions (see the following section),
although with lower conversion.
Tethered catalysts with sulfamoylamino (NSO2N) groups
were demonstrated by the group of Mohar as effective catalysts
for the ATH of a-CF3(CO) indanones through DKR.
[32b]
DKR has also been used by Ratovelomanana-Vidal et al.
in the asymmetric reduction of a-amino-b-keto esters (Figure
39).[63] Several examples are featured, each containing aromat-
ic substitution, which is important to control the reaction, and
no conversion was reported using non-tethered catalysts.
Fig. 35. Application of a non-chiral tethered catalyst.
Fig. 36. Application of ATH by Boehringer Ingelheim GmbH.
Fig. 37. ATH applied to the synthesis of an adrenergic receptor agonist.
Fig. 38. DKR coupled to ATH.
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The same group (in collaboration with Roche) also found
that the use of 3-C-tethered catalyst 8 was essential for the con-
version of a range of a-methoxy-b-ketoesters, notably, for sub-
strates in which R was an alkyl group (Figure 40).[51] Less
challenging substrates could be reduced effectively by the non-
tethered catalysts.
In another DKR application, Ts-DENEBV
R
9 was
employed in the synthesis of Omarigliptin, a type 2 diabetes
drug (Figure 41)[64] Initially,[65] the best conditions were
developed with the [RuCl(C6F5SO2DPEN)(p-cymene)] cata-
lyst, which has been repeatedly demonstrated as one of the best
catalysts in DKR applications.[66] Notably, FA is added to a
mixture of DABCO (in place of TEA) and substrate with
THF as a co-solvent to give optimal results in the DKR pro-
cess. A further experimental study[64] using Ts-DENEBV
R
9,
and only slightly adapted reaction conditions, concluded that
the performance of the tethered catalyst was superior in all
aspects, despite the presence of an tosyl group instead of the
C6F5SO2 group.
Although the great majority of research work on ATH cat-
alysts as tethered catalysts has focused on ketones, there have
been some limited studies on C5N reduction.[67] However,
this field is significantly less developed and the catalyst versatil-
ity is not as extensive, even with untethered catalysts, although
there are some very impressive examples, particularly of
cyclic imine reductions.[14,15,68–70] One very impressive recent
example of C5N reductions using a tethered catalyst was
reported by scientists at Merck, who found that catalyst
8 was particularly beneficial, and indeed superior to other
catalysts tested, in the reduction of an imine substrate to a pri-
mary amine during the synthesis of a target drug molecule
(Figure 42).[71]
7. Hydrogenation
Noyori and Ohkuma et al. have demonstrated that non-
tethered catalysts can be used in MeOH under hydrogenation
conditions that is, using hydrogen as the reducing agent,[72,73]
provided that they are converted into salts with weakly coordi-
nating anions. On the contrary, tethered complexes work well
in hydrogenation without such activation reactions, giving
products in excellent yields and ee values in many cases (Figure
43).[22] The achiral catalyst 25 was also tested in this applica-
tion and gave excellent results for the hydrogenation of alde-
hydes. The value of this application resides in the potential for
the catalytic reduction of aldehydes when other functional
groups are present (e.g., nitro, cyano, aromatic halides) that
may be reduced by heterogeneous hydrogenation catalysts.
The methoxy-substituted catalyst 34 also promotes AH of
ketones, in similar ee to the ATH reactions (Figure 44).[37]
Ts-DENEBV
R
9 was also reported to be active and effective
for the reduction of aryl ketones under AH conditions (Figure
45) and has also been shown to be capable of hydrogenation of
Fig. 39. ATH–DKR of a-amino-b-keto esters.
Fig. 40. ATH-DKR of a-methoxy-b-ketoesters.
Fig. 41. DKR in the synthesis of Omarigliptin, using catalyst Ts-DENEBV
R
9.
Fig. 42. Primary amine formation by ATH using catalyst 8.
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lactones.[24] Both the ruthenium chloride precatalyst and the
unsaturated (16e-) complexes were used in the reductions.
Although the ee values were essentially the same, better conver-
sions were achieved using the unsaturated complex (conditions:
3.0 MPa H2, 60 8C, MeOH, 18–20h, 0.1 mol% catalyst).
Kacˇer et al. tabulated the activity of Ru tethered catalysts
(7 and Ts-DENEBV
R
9) against a panel of cyclic imines, but
under the following conditions: TFA, MeOH, 15 bar H2,
40 8C.[74]
8. Tethered Rh(III) Derivatives
Alongside the development of Ru(II)/TsDPEN catalysts, sever-
al researchers reported isoelectronic complexes based on both
Rh(III) and Ir(III) (Figure 4); the major difference is the use of
a cyclopentadienyl ligand in place of the neutral arene to bal-
ance the charge and fulfil the 18-electron requirement.[16] This
class of complex was developed as a commercial product under
the trade name CATHyVR catalysts by Avecia (now NPIL).
Fig. 43. AHs using the tethered catalyst 8.
Fig. 44. AH products formed using catalyst 34.
Fig. 45. AH products formed using Ts-DENEBV
R
9.
Fig. 46. Synthesis of Rh(III) tethered complexes and products of ketone
ATH.
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In 2005, Wills et al. reported the synthesis and applica-
tions of the tethered analogue of the Rh(III)/TsDPEN/cyclo-
pentadienyl class of catalysts, 40, which was prepared by the
route shown in Figure 46, along with examples of results from
reduction reactions.[75–77] Pivotal to the success of the route
was the addition of a lithiated arene with a cyclopentadienone,
followed by elimination of water. The structure of the complex
was confirmed by X-ray crystallographic analysis, as was that of
the cyclohexyl diamine derivative catalyst, which gave excellent
results under aqueous conditions.[76]
As well as ketone reduction, tethered Rh(III) catalysts
have been applied to imine reduction[77] and additionally
to the ATH of quinolones, alongside the Ru(II) tethered
catalysts. In this application, the Rh catalysts gave products
with higher ee.[78] In 2010, Schom€acker et al reported a
supported version of the Rh(III)/TsDPEN tethered catalyst,
with linkage to a polymeric support. This proved to be
robust, recoverable and reusable in a range of reactions.[79,80]
A methoxy-substituted version of the Rh(III) tethered cata-
lyst, similar to a derivative reported by Wills et al.,[77] was
recently reported and proved to be active in a number of ATH
applications.[51,81]
The synthesis of the Ir(III) version of the tethered cata-
lyst has so far proved to be elusive and no purified catalyst
has been isolated to date. However, attempts to form the cat-
alyst in situ through the combination of the precursor ligand
with IrCl3 successfully resulted in the formation of a compe-
tent catalyst that was capable of reducing ketones in good
enantioselectivity.[77]
9. Summary and Outlook
Tethered ruthenium and rhodium catalysts come from a ratio-
nal improvement of the bifunctional design brilliantly intro-
duced by Noyori. However, over the past 10 years, the tethered
catalysts have proven to be successful beyond initial expecta-
tions, giving rise, in both academic and industrial laboratories,
to a number of innovative applications that could not be
achieved using first-generation catalysts. With the commercial-
ization of this class of catalysts by Johnson Matthey and Taka-
sago, the tethered catalysts have become indispensable tools
for the catalytic homogeneous reduction of C5O and C5N
functionalities, especially in the context of complex, multi-
functionalised substrates. The main advantages of the tethered
catalysts probably reside in their stability against deactivation
and in their activity under a broad range of reaction condi-
tions, even at low catalyst loading. More mechanistically relat-
ed transformations are been developed, which suggests that the
catalyst design will remain at the forefront of technology devel-
opment for many years.
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